Cervical cancer screening company TruScreen faces trading suspension for late annual report

Cervical cancer screening company TruScreen faces trading suspension for late annual report
Martin Dillon was reappointed chief executive of TruScreen in March. (Image: TruScreen)
Rebecca Stevenson
Cancer screening company TruScreen must file its late annual report by July 8 or face a trading suspension. In a notice to the New Zealand Exchange (NZX), market watchdog NZX RegCo said the firm should have filed its annual report by July 1. NZ RegCo said that because TruScreen missed that deadline, it had five business days following July 1 to publish the report to the NZX. If the report is not published, share trading for TruScreen will be suspended from the market from opening on Tuesday, July 9, until it is filed.TruScreen sh...

More Markets

NZ sharemarket shakes off Wall Street fall to end firm
Markets

NZ sharemarket shakes off Wall Street fall to end firm

New Zealand shares shook off weakness in overseas markets.

Seeka uncovers $350k fraud, sacks employee
Markets

Seeka uncovers $350k fraud, sacks employee

Three companies have been identified as being involved in the fraud, CEO says.

Smyth to stay on as Spark chair for another year
Markets

Smyth to stay on as Spark chair for another year

The past year had been one of the toughest in Spark's history, chair says.